Ms Cindy C Dodge, RPT | |
5 Roxbury Rd., Chatham Physical Therapy, Chatham, NY 12037 | |
(518) 392-7173 | |
Not Available |
Full Name | Ms Cindy C Dodge |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 5 Roxbury Rd., Chatham, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962899401 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 006078-1 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Cindy C Dodge, RPT 5 Roxbury Rd., Chatham Physical Therapy, Chatham, NY 12037 Ph: (518) 392-7173 | Ms Cindy C Dodge, RPT 5 Roxbury Rd., Chatham Physical Therapy, Chatham, NY 12037 Ph: (518) 392-7173 |
News Archive
The third quarter of 2009 has followed the same pattern as previous years, with low demand during the summer months and clinics closed for the summer. Production at the end of the quarter has been high with high demand at our clinics.
It may now be possible to identify the first-stage Parkinson's patients who will go on to develop dementia, according to a study conducted at the Institut universitaire de gériatrie de Montréal by Dr. Oury Monchi, PhD, and his postdoctoral student, Dr. Alexandru Hanganu, MD, PhD, both of whom are affiliated with Université de Montréal.
Oberthur Technologies - a global leader in the delivery of high security solutions to the Identity market - has obtained several common criteria certifications dedicated to key identity governmental products in 2009: Electronic passports, Governmental Multi-application cards and European Citizen Cards.
Data from interim analyses of a Phase III clinical study in patients with primary immune deficiency (PID) who received Baxter's HyQ were presented at the 26th meeting of the European Society for Immunodeficiencies (ESID) in Istanbul, Turkey. HyQ is an immune globulin (IG) therapy facilitated subcutaneously by recombinant human hyaluronidase, a dispersion and permeation enhancer.
Lloyd J. Old, M.D., is Director of the Ludwig Institute for Cancer Research (LICR) New York Branch. He is also Director of the Cancer Research Institute (CRI) Scientific Advisory Council, Director of the CRI/LICR Cancer Vaccine Collaborative, and Director of the CRI Cancer Vaccine Consortium. He has been a Member of the National Academy of Sciences since 1978.
› Verified 3 days ago
Catherine A. Dubois, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 43 Shufelt Rd, Chatham, NY 12037 Phone: 518-755-3171 |